|
ATCC
crispr cas9 engineered 293t cells Crispr Cas9 Engineered 293t Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pm37781397-67-0-10?v=ATCC Average 99 stars, based on 1 article reviews
crispr cas9 engineered 293t cells - by Bioz Stars,
2026-07
99/100 stars
|
Buy from Supplier |
|
Genecopoeia
crispr cas9 mediated gene knock Crispr Cas9 Mediated Gene Knock, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc08143319-82-17-31?v=Genecopoeia Average 94 stars, based on 1 article reviews
crispr cas9 mediated gene knock - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
BioResource International Inc
mouse es cell line rax-gfp (an eb5 derivative having the knock-in gfp gene in theoct3/4 locus) Mouse Es Cell Line Rax Gfp (An Eb5 Derivative Having The Knock In Gfp Gene In Theoct3/4 Locus), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pm37771660-264-7-27?v=BioResource+International+Inc Average 90 stars, based on 1 article reviews
mouse es cell line rax-gfp (an eb5 derivative having the knock-in gfp gene in theoct3/4 locus) - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Addgene inc
pd l1 deficient e g7 tumor cell line plenti crispr v2 plasmid Pd L1 Deficient E G7 Tumor Cell Line Plenti Crispr V2 Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc11027622-63-3-11?v=Addgene+inc Average 96 stars, based on 1 article reviews
pd l1 deficient e g7 tumor cell line plenti crispr v2 plasmid - by Bioz Stars,
2026-07
96/100 stars
|
Buy from Supplier |
|
KU Leuven
crispr/cas9 array platform Crispr/Cas9 Array Platform, supplied by KU Leuven, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pm30787394-32-5-36?v=KU+Leuven Average 90 stars, based on 1 article reviews
crispr/cas9 array platform - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
CLS Cell Lines Service GmbH
2os crispr nup96 snap cell line 2os Crispr Nup96 Snap Cell Line, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc12166345-129-17-21?v=CLS+Cell+Lines+Service+GmbH Average 94 stars, based on 1 article reviews
2os crispr nup96 snap cell line - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
OriGene
lzic knock out line generation lzic targeting crispr based knockout plasmid kit ![]() Lzic Knock Out Line Generation Lzic Targeting Crispr Based Knockout Plasmid Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pm30973299-181-0-12?v=OriGene Average 90 stars, based on 1 article reviews
lzic knock out line generation lzic targeting crispr based knockout plasmid kit - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
cntnap2 rabbit antibody ![]() Cntnap2 Rabbit Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc08410758__41467_2021_24358_MOESM16_ESM-34-17-20?v=GenScript+corporation Average 90 stars, based on 1 article reviews
cntnap2 rabbit antibody - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Genecopoeia
crispr cas9 mediated disruption ![]() Crispr Cas9 Mediated Disruption, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc05741473-97-0-21?v=Genecopoeia Average 94 stars, based on 1 article reviews
crispr cas9 mediated disruption - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Synthego Inc
crispr ki cell line generation crispr design ![]() Crispr Ki Cell Line Generation Crispr Design, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pm34113010-64-0-15?v=Synthego+Inc Average 86 stars, based on 1 article reviews
crispr ki cell line generation crispr design - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
OriGene
slk human shrna plasmid kit ![]() Slk Human Shrna Plasmid Kit, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc12139437-147-0-10?v=OriGene Average 93 stars, based on 1 article reviews
slk human shrna plasmid kit - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Addgene inc
crispr cas9 vector pac sgrna cas9 ![]() Crispr Cas9 Vector Pac Sgrna Cas9, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/locus+link/pmc07692951__ANIE___59___20659___s001-18-11-18?v=Addgene+inc Average 93 stars, based on 1 article reviews
crispr cas9 vector pac sgrna cas9 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell cycle (Georgetown, Tex.)
Article Title: Leucine zipper and ICAT domain containing (LZIC) protein regulates cell cycle transitions in response to ionizing radiation.
doi: 10.1080/15384101.2019.1601476
Figure Lengend Snippet: Figure 1. The loss of LZIC expression alters transcriptome under basal conditions and in response to ionizing radiation. (A) Venn diagram comparing the numbers of genes with significantly altered log-fold changes between LZIC KO clone vs CRISPR control cells in control and IR conditions. (B) Heatmaps representing Z-scores for genes comparing transcriptomic profiles in CRISPR control to LZIC KO Clone 1 cell lines in response to 5 Gy IR. (C) Heatmaps representing Z-scores for comparison of transcriptional profiles between CRISPR control and LZIC KO Clone 1 either under basal condition or following IR exposure. (D) Hallmark gene groups analyzed in GSEA and their associated FDR q-value (E) Barcode plots for significant GSEA hallmark gene groups. Microarray was repeated on two separate biological repeats with two technical repeats of each condition.
Article Snippet:
Techniques: Expressing, CRISPR, Control, Comparison, Microarray
Journal: Cell cycle (Georgetown, Tex.)
Article Title: Leucine zipper and ICAT domain containing (LZIC) protein regulates cell cycle transitions in response to ionizing radiation.
doi: 10.1080/15384101.2019.1601476
Figure Lengend Snippet: Figure 2. Late G2/M checkpoint arrest is perturbed following LZIC loss. (A) Cell cycle analysis of cell lines by propidium iodide staining. Cell lines were treated with 5 Gy IR and following a 24hr incubation harvested for analysis. Graphs are based on four separate biological repeats (B) Cell cycle analysis of LZIC KO Clone 2 and stable re-expression of LZIC-flag. Graphs based on three separate biological repeats. (C) p53 phosphorylation status in all cell lines, over a 4-h time course, following treatment with IR. A representative blot is shown from three separate biological repeats. (D) Activation of early G2/M checkpoint induction, following treatment with IR. The inclusion of Parental + ATMi provides a positive control for loss of early G2/M checkpoint activation. Graphs based on three separate biological repeats. (E) Quantification of phosphorylated serine 10 on Histone 3. Cells were treated with 2 Gy IR and harvested at 24 h. Images indicate staining profile with arrows to denote the quantified cells. Graphs based on three separate biological repeats. All statistical significance was determined with unpaired student T-Test, * = p-value < 0.05, n.s = non-significant. CRISPR control and LZIC KO Clones were compared to the parental line.
Article Snippet:
Techniques: Cell Cycle Assay, Staining, Incubation, Expressing, Phospho-proteomics, Activation Assay, Positive Control, CRISPR, Control, Clone Assay
Journal: Cell cycle (Georgetown, Tex.)
Article Title: Leucine zipper and ICAT domain containing (LZIC) protein regulates cell cycle transitions in response to ionizing radiation.
doi: 10.1080/15384101.2019.1601476
Figure Lengend Snippet: Figure 3. Cellular signaling for activation of G2/M checkpoint in response to IR is perturbed in LZIC KO cells. (A) Analysis of ATR and ATM phosphorylation status at 8 and 24-h post-treatment with 5 Gy IR. (*) indicates protein band corresponding to ATR protein. (B) Western blot analysis of checkpoint proteins at 8 h and 24 h in all cell types following treatment with 5 Gy IR. (C) Western blot analysis of Mitosis promoting factors at 8 and 24 h following treatment with 5 Gy IR. (D) Western blot analysis of major G2/M phosphatases, PP1 and PP2A, at 8 and 24 h following treatment with IR. (E) Schematic diagram of regulatory cascade showing key proteins involved in the G2/M cell cycle progression and their DNA damage-induced phosphorylation sites. All western blots shown are representative image of three separate biological repeats.
Article Snippet:
Techniques: Activation Assay, Phospho-proteomics, Western Blot
Journal: Cell cycle (Georgetown, Tex.)
Article Title: Leucine zipper and ICAT domain containing (LZIC) protein regulates cell cycle transitions in response to ionizing radiation.
doi: 10.1080/15384101.2019.1601476
Figure Lengend Snippet: Figure 4. Loss of LZIC leads to genome instability and poor prognosis in clear cell renal carcinoma. (A) Schematic outlining the development of aneuploidy following loss of G2/M checkpoint control. (B) Metaphase spread quantification of chromosome numbers from Parental, CRISPR control line, and LZIC KO Clone 1 and 2. Data from 3 biological repeats counting at least 17 spreads per replicate. Statistical significance was determined using unpaired student T-Test, *** = p-value < 0.001, n.s = non-significant. CRISPR control and LZIC KO clones were compared to the parental line in the untreated condition. (C) Kaplan Meier plot showing overall survival of patients stratified by LZIC expression. The calculated hazard ratios and significance is also included.
Article Snippet:
Techniques: Control, CRISPR, Clone Assay, Expressing
Journal: eBioMedicine
Article Title: SLK is mutated in individuals with a neurodevelopmental disorder
doi: 10.1016/j.ebiom.2025.105725
Figure Lengend Snippet: The effect of SLK deficiency on Paxillin localization and neuronal differentiation . (a) Immunofluorescence staining for Paxillin and Vinculin in fibroblasts derived from the index individual in Family 1 (IV:1) (SLK) and control (Control/WT) cell lines. Green and red represent Vinculin and Paxillin, respectively, while yellow indicates their colocalization. The scale bar in the bottom right corner denotes a length of 20 μm. (b) Anti-SLK immunostaining on control and SLK mutant patient fibroblasts, scale bar = 50 μM. ( c i ) SLK expression intensity in control vs SLK mutant fibroblasts (p < 0.0001 (unpaired t-test with Welch's correction)). (c ii ) Normalized SLK expression percentage in control vs SLK mutant fibroblasts (p < 0.0001 (unpaired t-test with Welch's correction)). (c iii ) Percentage change in cell density between control and SLK mutant fibroblasts (Kruskal–Wallis test, p = 0.1039). (d) Schematic representation of the transdifferentiation protocol (top panel). Representative images of control and SLK patient derived fibroblasts (PT D3 refers to 3 days post transduction with Brn2 and Ascl1 lentivirus, scale bar = 300 μM), transdifferentiated neurons (PT D12, 12 days after transduction; scale bar = 300 μM) and transdifferentiated fibroblasts were stained with Tubulin β-III and Map2. Scale bar = 50 μM. (e i ) Statistical analysis of the transdifferentiated SLK patient derived fibroblasts. (p = 0.0256 (Mann Whitney test of normalized cluster size)) and cell body diameter (e ii , p = 0.1229 (Unpaired t-test with Welch's correction of the number of neurites)). (e iii , p = 0.0471(Unpaired t-test with Welch's correction of the number of neurites)) and length of neurites (e iv , p = 0.7643 (Unpaired t-test with Welch's correction of the number of neurites)). (f) Schematic representation of lentiviral shRNA mediated knockdown (KD) of SLK followed by transdifferentiation to produce neurons (upper panel). shRNA mediated knockdown (KD) of SLK derived fibroblasts indicating the efficiency of the KD (bottom panel, Scale bar = 50 μM). (g i ) Analysis in fibroblasts reveals that the shRNA mediated KD of SLK resulted in a marked reduction in SLK expression intensity (p < 0.0001 (Mann–Whiteny test)). ( g ii ) Normalized SLK expression percentage decrease (Control vs shRNA mediated KD of SLK fibroblasts, (p < 0.0001 (Mann–Whiteny test)). (g iii ) Percentage change in cell density between control, scrambled shRNA and shRNA mediated KD of SLK fibroblasts (p = 0.0179 (Kruskal–Wallis test)). (h) Representative images of control, scrambled shRNA and shRNA mediated KD of SLK transdifferentiated neurons at 20× magnification. Scale bar = 300 μM. Please note the reduction in the SLK intensity in neurons derived from shRNA KD fibroblasts. (i i ) Normalized percentage change in SLK expression intensity (Control vs scrambled shRNA vs shRNA mediated KD of SLK fibroblasts, p = 0.0089 (Brown-Forsythe and Welch ANOVA tests) and ( i ii , p = 0.1773 (Kruskal–Wallis test, of the diameter of cell body)), number of neurites (I iii , p = 0.0178 (Kruskal–Wallis test, of the diameter of cell body)) and neurite length (I iv , p < 0.0001 (Kruskal–Wallis test, of the diameter of cell body)).
Article Snippet:
Techniques: Immunofluorescence, Staining, Derivative Assay, Control, Immunostaining, Mutagenesis, Expressing, Transduction, MANN-WHITNEY, shRNA, Knockdown